These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3177430)

  • 21. Antimalarial drugs for treating and preventing malaria in pregnant and lactating women.
    Saito M; Gilder ME; McGready R; Nosten F
    Expert Opin Drug Saf; 2018 Nov; 17(11):1129-1144. PubMed ID: 30351243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antimalarial drugs in contemporary dermatologic therapy].
    Kiedrowicz M; Kacalak-Rzepka A; Bielecka-Grzela S; Maleszka R
    Ann Acad Med Stetin; 2011; 57(1):38-44. PubMed ID: 22593989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.
    Steketee RW; Wirima JJ; Slutsker L; Roberts JM; Khoromana CO; Heymann DL; Breman JG
    Am J Trop Med Hyg; 1996; 55(1 Suppl):24-32. PubMed ID: 8702034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.
    Abarientos C; Sperber K; Shapiro DL; Aronow WS; Chao CP; Ash JY
    Expert Opin Drug Saf; 2011 Sep; 10(5):705-14. PubMed ID: 21417950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discontinuation of antimalarial drugs in systemic lupus erythematosus.
    Wang C; Fortin PR; Li Y; Panaritis T; Gans M; Esdaile JM
    J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of preeclampsia with hydroxychloroquine: a review.
    Abd Rahman R; DeKoninck P; Murthi P; Wallace EM
    J Matern Fetal Neonatal Med; 2018 Feb; 31(4):525-529. PubMed ID: 28142291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pregnancy and systemic lupus erythematosus].
    Wechsler B; Lê Thi Huong D; Piette JC
    Ann Med Interne (Paris); 1999 Sep; 150(5):408-18. PubMed ID: 10544751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to ophthalmologic monitoring for antimalarial toxicity in a lupus cohort.
    Bernatsky S; Pineau C; Joseph L; Clarke A
    J Rheumatol; 2003 Aug; 30(8):1756-60. PubMed ID: 12913931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review.
    Ruiz-Irastorza G; Ramos-Casals M; Brito-Zeron P; Khamashta MA
    Ann Rheum Dis; 2010 Jan; 69(1):20-8. PubMed ID: 19103632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.
    Kreuter A; Gaifullina R; Tigges C; Kirschke J; Altmeyer P; Gambichler T
    Arch Dermatol; 2009 Mar; 145(3):244-8. PubMed ID: 19289751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature.
    Osadchy A; Ratnapalan T; Koren G
    J Rheumatol; 2011 Dec; 38(12):2504-8. PubMed ID: 22002012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimalarial therapy in SLE.
    Lanham JG; Hughes GR
    Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
    [No Abstract]   [Full Text] [Related]  

  • 33. Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus.
    Koh JH; Ko HS; Kwok SK; Ju JH; Park SH
    Lupus; 2015 Feb; 24(2):210-7. PubMed ID: 25305214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Maculopathy in a lupus patient after taking antimalarial drugs].
    Abdelkhalek R; Hanafi Y
    Pan Afr Med J; 2014; 18():146. PubMed ID: 25419284
    [No Abstract]   [Full Text] [Related]  

  • 35. Perinatal outcomes in women with systemic lupus erythematosus.
    Kleinman D; Katz VL; Kuller JA
    J Perinatol; 1998; 18(3):178-82. PubMed ID: 9659644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregnancy in Women with Systemic Lupus Erythematosus: A Retrospective Study of 83 Pregnancies at a Single Centre.
    Chen S; Sun X; Wu B; Lian X
    Int J Environ Res Public Health; 2015 Aug; 12(8):9876-88. PubMed ID: 26295404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort.
    Spinelli FR; Moscarelli E; Ceccarelli F; Miranda F; Perricone C; Truglia S; Garufi C; Massaro L; Morello F; Alessandri C; Valesini G; Conti F
    Lupus; 2018 Sep; 27(10):1616-1623. PubMed ID: 29954281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Eye toxicity of antimalarial agents].
    Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
    An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature.
    Costedoat-Chalumeau N; Amoura Z; Huong DL; Lechat P; Piette JC
    Autoimmun Rev; 2005 Feb; 4(2):111-5. PubMed ID: 15722258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
    Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
    Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.